← Eichor
Study identifier: NCT07585929 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

Condition: Stage IIIC  ·  Sponsor: All India Institute of Medical Sciences

PhaseNA
Planned participants150
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersNo

About this study

Cervical cancer is a significant cause of morbidity and mortality among women worldwide. Radiotherapy, in combination with chemotherapy or as a standalone treatment, is an effective treatment option for cervical cancer. However, traditional radiotherapy has its limitations, such as the potential for damage to surrounding healthy tissues. Stereotactic Body RadioTherapy (SBRT) is a newer radiotherapy technique that delivers high doses of radiation to the tumor with minimal damage to the surrounding tissues. This study aims to evaluate the safety of Stereotactic Body RadioTherapy to involved node in cervical cancer.

This description comes directly from the study's public registry record.

Talk to the study team

KARUN KAMBOJ, MD  ·  9416613389  ·  karunkamboj04@aiims.edu

Always discuss trial participation with your own doctor first.

Locations (3)

All India Institute of Medical SciencesDelhi, National Capital Territory of Delhi, IndiaRecruiting
Karun KambojDelhi, National Capital Territory of Delhi, IndiaRecruiting
National Cancer Institute, All India Institute of Medical Sciences, New Delhi, IndiaNew Delhi, New Delhi, IndiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07585929